Blagov, A.V.; Goncharov, A.G.; Babich, O.O.; Larina, V.V.; Orekhov, A.N.; Melnichenko, A.A.
Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson’s Disease. Pharmaceutics 2022, 14, 2514.
https://doi.org/10.3390/pharmaceutics14112514
AMA Style
Blagov AV, Goncharov AG, Babich OO, Larina VV, Orekhov AN, Melnichenko AA.
Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson’s Disease. Pharmaceutics. 2022; 14(11):2514.
https://doi.org/10.3390/pharmaceutics14112514
Chicago/Turabian Style
Blagov, Alexander V., Andrey G. Goncharov, Olga O. Babich, Viktoriya V. Larina, Alexander N. Orekhov, and Alexandra A. Melnichenko.
2022. "Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson’s Disease" Pharmaceutics 14, no. 11: 2514.
https://doi.org/10.3390/pharmaceutics14112514
APA Style
Blagov, A. V., Goncharov, A. G., Babich, O. O., Larina, V. V., Orekhov, A. N., & Melnichenko, A. A.
(2022). Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson’s Disease. Pharmaceutics, 14(11), 2514.
https://doi.org/10.3390/pharmaceutics14112514